Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma
James R Whittle, Jason D Lickliter, Hui K Gan, et al.
The Journal of Urology
|
November 17, 2009
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder
Scott A MacDiarmid, Kenneth M Peters, S Abbas Shobeiri, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma
Lauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Molecular Cancer Therapeutics
|
March 2, 2018
Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma
Sharon M Sagnella, Jennifer Trieu, Himanshu Brahmbhatt, et al.
Nature Biotechnology
|
June 30, 2009
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
Jennifer A MacDiarmid, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, et al.
Cancer Cell
|
March 19, 2020
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
Sharon M Sagnella, Lu Yang, Gemma E Stubbs, et al.
The Journal of Urology
|
July 21, 2009
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial
Kenneth M Peters, Scott A Macdiarmid, Leslie S Wooldridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2013
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
G Reid, M E Pel, M B Kirschner, et al.
Plos One
|
October 24, 2017
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models
Mohamed A Alfaleh, Christopher B Howard, Ilya Sedliarou, et al.
Oncotarget
|
October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Anthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma
James R Whittle, Jason D Lickliter, Hui K Gan, et al.
The Journal of Urology
|
November 17, 2009
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder
Scott A MacDiarmid, Kenneth M Peters, S Abbas Shobeiri, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma
Lauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Molecular Cancer Therapeutics
|
March 2, 2018
Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma
Sharon M Sagnella, Jennifer Trieu, Himanshu Brahmbhatt, et al.
Nature Biotechnology
|
June 30, 2009
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
Jennifer A MacDiarmid, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, et al.
Cancer Cell
|
March 19, 2020
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
Sharon M Sagnella, Lu Yang, Gemma E Stubbs, et al.
The Journal of Urology
|
July 21, 2009
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial
Kenneth M Peters, Scott A Macdiarmid, Leslie S Wooldridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2013
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
G Reid, M E Pel, M B Kirschner, et al.
Plos One
|
October 24, 2017
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models
Mohamed A Alfaleh, Christopher B Howard, Ilya Sedliarou, et al.
Oncotarget
|
October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Anthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
Page
of 8